Cape Town based, biotech company, Biovac, has begun local manufacturing of global pharmaceutical company, Sanofi Pasteur's six-in-one paediatric vaccine. This is the...South Africa
A $130m SA-based study of a promising vaccine for HIV has ended in failure after an interim analysis showed it was no more effective than placebo, The Washington Post...Research Africa
An innovative clinical trial conducted by the University of Cape Town-based SA Tuberculosis Vaccine Initiative and the Desmond Tutu HIV Foundation provides encouraging...
April 18th, 2018The Biovac Institute (Biovac) has been awarded a manufacturing licence by a South African regulator, taking it one step closer to realising the government’s ambition...
Scientists from the University of Cape Town-based South African Tuberculosis Vaccine Initiative (SATVI) and the Desmond Tutu HIV Foundation have announced that they will...Medico-Legal
International experts on liability law are divided on what the decision by the European Court of Justice (ECJ) on allowing scientifically unproven claims about vaccine...Weekly Roundup
Two companies making vaccines to help the world eradicate polio are failing to produce enough, so many countries should prepare to give lower doses to make stocks last,...Africa
Fav-Afrique – the anti-venom that can counteract bites from Africa's most dangerous snakes — reaches its expiry date for all remaining stocks at the end of...News Update
An NIH-led safety and efficacy trial of an experimental HIV vaccine regimen has begun in SA, with experimental vaccines from Sanofi Pasteur and Novartis....
